We are live on
!
Find out more
MCM
Mitchell Capital Management Portfolio holdings
AUM
$657M
1-Year Est. Return
64.28%
This Fund
S&P 500
This Quarter
Est. Return
-16.24%
1 Year Est. Return
+64.28%
3 Year Est. Return
+219.19%
5 Year Est. Return
+290.67%
10 Year Est. Return
+1,411.54%
AUM
$357M
AUM Growth
-$90M
(-20%)
Cap. Flow
-$9.59M
Cap. Flow
% of AUM
-2.69%
Top 10 Holdings %
Top 10 Hldgs %
34.57%
Holding
140
New
13
Increased
67
Reduced
32
Closed
20
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$3.4M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$3.17M |
| 3 |
Vistra
VST
|
+$2.53M |
| 4 |
Copart
CPRT
|
+$2.19M |
| 5 |
Exelon
EXC
|
+$2.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$3.09M |
| 2 |
Intuitive Surgical
ISRG
|
+$2.94M |
| 3 |
Royal Caribbean
RCL
|
+$2.9M |
| 4 |
Charter Communications
CHTR
|
+$2.64M |
| 5 |
Generac Holdings
GNRC
|
+$2.57M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.83% |
| 2 | Healthcare | 14.43% |
| 3 | Financials | 11.78% |
| 4 | Consumer Discretionary | 8.98% |
| 5 | Communication Services | 8.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
MKS Inc
MKSI
$20.7B
| – | – |
-15,810
| Closed | -$2.37M |
|
|
127
Royal Caribbean
RCL
$82.9B
| – | – |
-34,677
| Closed | -$2.9M |
|
128
TotalEnergies
TTE
$193B
| – | – |
-17,452
| Closed | -$882K |
|
129
Uber
UBER
$155B
| – | – |
-55,563
| Closed | -$1.98M |
|
130
Vale
VALE
$58.7B
| – | – |
-58,589
| Closed | -$1.17M |
|
|
CERN
131
DELISTED
Cerner Corp
CERN
| – | – |
-3,823
| Closed | -$358K |
|
Similar funds
BL
PIM
ACM
PAI
DC
FAM
AG
BCP
Mitchell Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Mitchell Capital Management held 140 positions worth $357M, down 20% from $447M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Mitchell Capital Management's Q2 2022 filing shows 13 new, 67 increased, 32 reduced and 20 closed positions. Its largest new stake was Vertex Pharmaceuticals: 11,826 shares worth $3.33M. The largest sale was DuPont de Nemours, an estimated $3.09M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 27% a quarter earlier, followed by Healthcare and Financials.
- Mitchell Capital Management's largest Q2 2022 buy was Vertex Pharmaceuticals: 11,826 shares worth $3.33M.
- Mitchell Capital Management added most to Johnson & Johnson in Q2 2022, an estimated $3.4M increase.
- Mitchell Capital Management's biggest Q2 2022 reduction was Costco, cutting an estimated $2.05M.
- Mitchell Capital Management fully exited DuPont de Nemours in Q2 2022, selling an estimated $3.09M.
- Mitchell Capital Management's ten largest holdings make up 35% of its $357M portfolio in Q2 2022.
- Mitchell Capital Management opened 13 new positions and closed 20 in Q2 2022.
- Mitchell Capital Management's portfolio value fell 20% quarter-over-quarter to $357M.
Based on Mitchell Capital Management's 13F filing for Q2 2022, filed 29 Jul 2022.